EPIEN Medical, Inc. (EPMI)

EPIEN Medical will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.25 - $6.25
Shares Offered
4,190,476
Deal Size
$22.00M
Chart not available yet
Data will show when the stock starts trading.
Market Cap 74.13M
Revenue (ttm) 1.27M
Net Income (ttm) -3.80M
Shares Out 14.12M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About EPMI

EPIEN Medical is a specialty medical devices company that is developing products for treatment of oral inflammation and acute and chronic wounds based on our chemical formulations that act as aggressive desiccation and debriding agents. We refer to this proprietary process as Desiccation Shock Technology (“DST”). Eleven published clinical trials have shown that our products reduce and, very often, eliminate the need for antibiotics to treat topical infectious wounds, including oral infections and open infectious wounds. Standard treatments ... [Read more]

Industry Health Care
Founded 1991
CEO Reginald R. Dupre
Employees 13
Stock Exchange NASDAQ
Ticker Symbol EPMI
Full Company Profile

Financial Performance

In 2021, EPIEN Medical's revenue was $1.39 million, an increase of 19.69% compared to the previous year's $1.16 million. Losses were -$3.14 million, 85.6% more than in 2020.

Financial Statements

News

EPIEN Medical IPO Registration Document (S-1)

EPIEN Medical has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC